Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

		Phase:		Phase 1/2

		Treatment ID#:		1168

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed RATIONALE: Cilengitide may stop the growth of cancer by stopping blood flow to the tumor. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining cilengitide with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase I/II trial to study the effectiveness of combining cilengitide with radiation therapy in treating patients who have newly diagnosedglioblastoma multiforme.

		Last Updated:		05/01/2007

		Tumor Types:		Glioblastoma Multiforme Gliosarcoma


		Comments:

		Treatment Type:		Chemotherapy Radiation

		Contact:		Dr.Tom MikKelsen MD, FRCP(C) Co-Director Henry Ford Hospital Hermelin Brain Tumor Center E&R3096 Henry Ford Hospital 2799 West Grand Blvd Detroit, MI 48202- USA Phone: 313 916-8641 Fax: 313 916-9855 E-mail: nstom@neuro.hfh.edu Website: www.nabtt.org/henry.html

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By